GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » Price-to-Operating-Cash-Flow

Guangdong Hybribio Biotech Co (SZSE:300639) Price-to-Operating-Cash-Flow : 18.40 (As of May. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co Price-to-Operating-Cash-Flow?

As of today (2024-05-22), Guangdong Hybribio Biotech Co's share price is ¥6.00. Guangdong Hybribio Biotech Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.33. Hence, Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow Ratio for today is 18.40.

The historical rank and industry rank for Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:300639' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.33   Med: 33.53   Max: 110.48
Current: 18.4

During the past 12 years, Guangdong Hybribio Biotech Co's highest Price-to-Operating-Cash-Flow Ratio was 110.48. The lowest was 4.33. And the median was 33.53.

SZSE:300639's Price-to-Operating-Cash-Flow is ranked better than
50% of 114 companies
in the Medical Diagnostics & Research industry
Industry Median: 18.4 vs SZSE:300639: 18.40

Guangdong Hybribio Biotech Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥-0.09. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.33.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Guangdong Hybribio Biotech Co was -83.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 3.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 53.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 35.80% per year.

During the past 12 years, Guangdong Hybribio Biotech Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 118.70% per year. The lowest was 3.90% per year. And the median was 34.90% per year.


Guangdong Hybribio Biotech Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Hybribio Biotech Co Price-to-Operating-Cash-Flow Chart

Guangdong Hybribio Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.68 26.32 13.69 5.65 16.41

Guangdong Hybribio Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.87 6.35 7.81 16.41 21.66

Competitive Comparison of Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow falls into.



Guangdong Hybribio Biotech Co Price-to-Operating-Cash-Flow Calculation

Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=6.00/0.326
=18.40

Guangdong Hybribio Biotech Co's Share Price of today is ¥6.00.
Guangdong Hybribio Biotech Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.33.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Guangdong Hybribio Biotech Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Hybribio Biotech Co (SZSE:300639) Business Description

Traded in Other Exchanges
N/A
Address
D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.

Guangdong Hybribio Biotech Co (SZSE:300639) Headlines

No Headlines